Table 5 Outcome by different CD20... | American Society of Hematology

Table 5

Outcome by different CD20 expression cut points in precursor B-cell ALL: pre-rituximab era

Age, y	Parameter (percent at 3 y)	Hyper-CVAD						VAD/CVAD
Age, y	Parameter (percent at 3 y)	< 10	≥ 10	< 20	≥ 20	< 30	≥ 30	< 10	≥ 10	< 20	≥ 20	< 30	≥ 30
≤ 30	CRD	69	33*	68	22*	64	20*	50	21	65	15*	55	27
	OS	90	45*	85	35*	82	30*	40	40	50	35	44	41
31-59	CRD	64	28*	56	30*	47	35	20	20	18	18	18	18
	OS	50	27*	54	28*	35	35	12	25	15	30	14	35
≥ 60	CRD	42	0	43	0	42	0	54	12	35	16	30	0
	OS	18	22	20	20	20	22	12	6	8	12	10	0

Age, y	Parameter (percent at 3 y)	Hyper-CVAD						VAD/CVAD
Age, y	Parameter (percent at 3 y)	< 10	≥ 10	< 20	≥ 20	< 30	≥ 30	< 10	≥ 10	< 20	≥ 20	< 30	≥ 30
≤ 30	CRD	69	33*	68	22*	64	20*	50	21	65	15*	55	27
	OS	90	45*	85	35*	82	30*	40	40	50	35	44	41
31-59	CRD	64	28*	56	30*	47	35	20	20	18	18	18	18
	OS	50	27*	54	28*	35	35	12	25	15	30	14	35
≥ 60	CRD	42	0	43	0	42	0	54	12	35	16	30	0
	OS	18	22	20	20	20	22	12	6	8	12	10	0

ρ <.05 for comparator of above and below specified percent CD20 expression for CRD or OS.